Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
---|---|---|---|---|
Novo Nordisk AS, Class B | Equity | 629,450 | $89,920,814.00 | 4.46% |
Capital Group Central Cash Fund | Short Term | 863,150 | $86,314,964.00 | 4.28% |
ASML Holding NV | Equity | 63,518 | $65,531,340.00 | 3.25% |
SAP SE | Equity | 289,144 | $58,706,307.00 | 2.91% |
Safran SA | Equity | 261,721 | $55,062,358.00 | 2.73% |
AstraZeneca PLC | Equity | 336,476 | $52,455,281.00 | 2.6% |
TotalEnergies SE | Equity | 749,620 | $49,961,459.00 | 2.48% |
Taiwan Semiconductor Manufacturing Co., Ltd. (ADR) | Equity | 260,943 | $45,354,503.00 | 2.25% |
London Stock Exchange Group PLC | Equity | 348,689 | $41,332,510.00 | 2.05% |
L'Oreal SA, non-registered shares | Equity | 78,294 | $34,426,963.00 | 1.71% |
Nestle SA | Equity | 329,183 | $33,602,189.00 | 1.67% |
EssilorLuxottica SA | Equity | 147,868 | $31,727,739.00 | 1.57% |
ABB, Ltd. | Equity | 563,282 | $31,182,196.00 | 1.55% |
Keyence Corp. | Equity | 69,020 | $30,449,925.00 | 1.51% |
ITOCHU Corp. | Equity | 604,500 | $29,661,369.00 | 1.47% |